Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1363531 | 0.82 | L3MBTL1 (0.55) | CTDSP1ALDH1A1HSD17B10MAPTCYP1A2 | |
| Benzene SCHEMBL1720409 | 0.81 | CHRNB2 (0.59) | CTDSP1ALDH1A1HSD17B10MAPTCYP1A2 | |
| SCHEMBL442790 | 0.81 | CHRNB2 (0.59) | CTDSP1ALDH1A1HSD17B10MAPTCYP1A2 | |
| SCHEMBL31147823 | 0.81 | L3MBTL1 (0.53) | CTDSP1ALDH1A1HSD17B10MAPTCYP1A2 | |
| Hydrochloric Acid SCHEMBL27606948 | 0.81 | L3MBTL1 (0.53) | CTDSP1ALDH1A1HSD17B10MAPTCYP1A2 | |
| SCHEMBL24123006 | 0.80 | MAPT (0.54) | CTDSP1ALDH1A1MAPTSMN1; SMN2MEN1 | |
| SCHEMBL30408509 | 0.80 | MAPT (0.54) | CTDSP1ALDH1A1MAPTSMN1; SMN2MEN1 | |
| SCHEMBL4912307 | 0.79 | ALDH1A1 (0.50) | CTDSP1ALDH1A1HSD17B10MAPTCYP1A2 | |
| Ethylene SCHEMBL9312122 | 0.79 | L3MBTL1 (0.52) | CTDSP1ALDH1A1HSD17B10MAPTCYP1A2 | |
| SCHEMBL1396267 | 0.79 | ALDH1A1 (0.52) | CTDSP1ALDH1A1HSD17B10MAPTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4727818-B2 | — | — | 2011-07-20 | — | — | JP | claimed |
| EP-1128730-B1 | ANTIMICROBIAL COMPOSITION COMPRISING AN OXIDOREDUCTASE AND AN ENHANCING AGENT OF THE N-HYDROXYANILIDE-TYPE | NOVOZYMES AS (DK) | 2003-05-02 | — | — | EP | claimed |
| JP-2002529380-A | — | — | 2002-09-10 | — | — | JP | claimed |
| US-20020094331-A1 | ANTIMICROBIAL COMPOSITION CONTAINING AN OXIDOREDUCTASE AND AN ENHANCER OF THER N-HYDROXYANILIDE-TYPE | NOVOZYMES A/S (DK) | 2002-07-18 | — | — | US | claimed |
| EP-1128730-A1 | ANTIMICROBIAL COMPOSITION COMPRISING AN OXIDOREDUCTASE AND AN ENHANCING AGENT OF THE N-HYDROXYANILIDE-TYPE | Novozymes A/S (DK) | 2001-09-05 | — | — | EP | claimed |
| WO-2000027204-A1 | ANTIMICROBIAL COMPOSITION COMPRISING AN OXIDOREDUCTASE AND AN ENHANCING AGENT OF THE N-HYDROXYANILIDE-TYPE | NOVOZYMES A/S (DK) | 2000-05-18 | — | — | WO | claimed |
| EP-0247476-B1 | HYDROXYPHENYL URETHANES, PROCESS FOR THEIR MANUFACTURE, THEIR USES AND CHLOROFORMATES COMPRISING HYDROXYPHENYL URETHANE GROUPS | BAYER AG (DE) | 1990-12-27 | — | — | EP | claimed |
| EP-0247483-A2 | Process for the preparation of hydroxyphenyl urethanes | BAYER AG (DE) | 1987-12-02 | — | — | EP | claimed |
| EP-0247476-A1 | Hydroxyphenyl urethanes, process for their manufacture, their uses and chloroformates comprising hydroxyphenyl urethane groups | BAYER AG (DE) | 1987-12-02 | — | — | EP | claimed |
| WO-2025261983-A1 | USE OF COMPOUNDS AND METHOD FOR ELECTROCHEMICAL DISINTEGRATION | Rheinisch-Westfälische Technische Hochschule Aachen, abgekürzt RWTH Aachen, Körperschaft des öffentlichen Rechts (DE) | 2025-12-26 | — | — | WO | disclosed |
| WO-2025242789-A1 | METHOD FOR PRODUCING REINFORCED TEXTILE FIBER COMPOSITIONS | LIGAMORE APS (DK) | 2025-11-27 | — | — | WO | disclosed |
| EP-3444337-B1 | METHOD OF CLEANING | PROCTER & GAMBLE (US) | 2024-12-18 | — | — | EP | disclosed |
| EP-3444336-B1 | CLEANING AGENT | PROCTER & GAMBLE (US) | 2024-05-08 | — | — | EP | disclosed |
| US-20210147765-A9 | CLEANING KIT | THE PROCTER AND GAMBLE COMPANY | 2021-05-20 | — | — | US | disclosed |
| EP-0247483-A2 | Process for the preparation of hydroxyphenyl urethanes | BAYER AG (DE) | 1987-12-02 | — | — | EP | disclosed |
| US-4657906-A | CARDIOVASCULAR DISORDERS | SMITH KLINE & FRENCH LABORATORIES LTD. (GB) | 1987-04-14 | — | — | US | disclosed |
| US-4556711-A | CARDIOTONIC AGENTS | SMITH KLINE & FRENCH LABORATORIES LTD. (US) | 1985-12-03 | — | — | US | disclosed |
| EP-0096517-A2 | Aryl pyrazinones | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1983-12-21 | — | — | EP | disclosed |
| US-3943096-A | Use of hydroxyphenylurethanes for stabilising elastomers | CIBA-GEIGY CORPORATION (US) | 1976-03-09 | — | — | US | disclosed |
| US-3943096-A | Use of hydroxyphenylurethanes for stabilising elastomers | CIBA-GEIGY CORPORATION (US) | 1976-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020094331-A1 | ANTIMICROBIAL COMPOSITION CONTAINING AN OXIDOREDUCTASE AND AN ENHANCER OF THER N-HYDROXYANILIDE-TYPE | LPO, MPO, LCT | CTDSP1 2209/4885ALDH1A1 406/4885HSD17B10 226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.